Healthcare >> CEO Interviews >> July 5, 2004
HEINRICH GUGGER is President and Chief Executive Officer of Paradigm
Genetics. He brings more than 20 years of multi-industry management
experience to Paradigm. Prior to joining the company in July 2002, Dr.
Gugger was President of Syngenta Crop Protection Inc., a merger of
Zeneca Agchemicals and Novartis Crop Protection. He led the $2 billion
business through the North American merger planning and integration and
was instrumental in the company's introduction of 10 new products at
formulation level in its first nine months. From 1995 to 1998, Dr.
Gugger served as Head of Global Business Unit Fungicides for Novartis
AG. Prior to that, he served as Ciba-Geigy's Head of Global Business
Unit Electronic Materials, a global leader in providing polymeric
materials to the printed wiring board and chip manufacturing industry.
He began his professional career as a research scientist with Ciba-Geigy
in Switzerland before joining Spectra-Physics, Inc., a laser and
analytical instrumentation company, in 1988. Dr. Gugger serves on the
Board of Directors of the North Carolina Biotechnology Institute. He
received his PhD in Inorganic and Physical Chemistry from the University
of Bern, Switzerland. Dr. Gugger was an IBM World Trade Post Doctoral
Fellow in Applied Physics at the IBM Research Division in San Jose,
California, and was supported by a grant from the Swiss National Science
Foundation. Profile
Dr. Gugger: Paradigm Genetics is a biotechnology company applying its
proprietary systems biology platform to the discovery of safer,
